» Articles » PMID: 39093977

Caspase-2 is Essential for Proliferation and Self-renewal of Nucleophosmin-mutated Acute Myeloid Leukemia

Abstract

Mutation in nucleophosmin (NPM1) causes relocalization of this normally nucleolar protein to the cytoplasm (NPM1c+). Despite NPM1 mutation being the most common driver mutation in cytogenetically normal adult acute myeloid leukemia (AML), the mechanisms of NPM1c+-induced leukemogenesis remain unclear. Caspase-2 is a proapoptotic protein activated by NPM1 in the nucleolus. Here, we show that caspase-2 is also activated by NPM1c+ in the cytoplasm and DNA damage-induced apoptosis is caspase-2 dependent in but not in AML cells. Strikingly, in + cells, caspase-2 loss results in profound cell cycle arrest, differentiation, and down-regulation of stem cell pathways that regulate pluripotency including impairment of the AKT/mTORC1 pathways, and inhibition of Rictor cleavage. In contrast, there were minimal differences in proliferation, differentiation, or the transcriptional profile of cells lacking caspase-2. Our results show that caspase-2 is essential for proliferation and self-renewal of AML cells expressing mutated NPM1. This study demonstrates that caspase-2 is a major effector of NPM1c+ function.

Citing Articles

Chemoproteomics Identifies State-Dependent and Proteoform-Selective Caspase-2 Inhibitors.

Castellon J, Ofori S, Burton N, Julio A, Turmon A, Armenta E J Am Chem Soc. 2024; 146(22):14972-14988.

PMID: 38787738 PMC: 11832190. DOI: 10.1021/jacs.3c12240.

References
1.
Gundry M, Brunetti L, Lin A, Mayle A, Kitano A, Wagner D . Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9. Cell Rep. 2016; 17(5):1453-1461. PMC: 5087995. DOI: 10.1016/j.celrep.2016.09.092. View

2.
Park S, Chapuis N, Tamburini J, Bardet V, Cornillet-Lefebvre P, Willems L . Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia. Haematologica. 2009; 95(5):819-28. PMC: 2864389. DOI: 10.3324/haematol.2009.013797. View

3.
Hayun M, Zaatra M, Itzkovich C, Sahar D, Rosenberg D, Filatova M . ERK Activity in Immature Leukemic Cells Drives Clonal Selection during Induction Therapy for Acute Myeloid Leukemia. Sci Rep. 2020; 10(1):8349. PMC: 7239856. DOI: 10.1038/s41598-020-65061-6. View

4.
Issa G, Bidikian A, Venugopal S, Konopleva M, DiNardo C, Kadia T . Clinical outcomes associated with NPM1 mutations in patients with relapsed or refractory AML. Blood Adv. 2022; 7(6):933-942. PMC: 10027507. DOI: 10.1182/bloodadvances.2022008316. View

5.
Ho L, Taylor R, Dorstyn L, Cakouros D, Bouillet P, Kumar S . A tumor suppressor function for caspase-2. Proc Natl Acad Sci U S A. 2009; 106(13):5336-41. PMC: 2664004. DOI: 10.1073/pnas.0811928106. View